PAR 4.17% 25.0¢ paradigm biopharmaceuticals limited..

Ann: Trading Halt, page-177

  1. 101 Posts.
    lightbulb Created with Sketch. 7
    Sorrry Mozz but couldn't a CR have been done concurrently with release of good 008 results and therefore done at a premium!. Instos would have to take it or buy on market with a surging share price.

    The idea of extra upside for them is also rubbish IMO. There is plenty of major events in the pipeline as you have stated many times and positive 008 results is a masive derisk/ value for the stock.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
25.0¢
Change
0.010(4.17%)
Mkt cap ! $83.95M
Open High Low Value Volume
24.5¢ 25.0¢ 24.5¢ $51.91K 208.0K

Buyers (Bids)

No. Vol. Price($)
1 105837 25.0¢
 

Sellers (Offers)

Price($) Vol. No.
25.5¢ 17704 3
View Market Depth
Last trade - 10.18am 27/06/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.